Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2

por Mulvihill, Erin E.
Publicado no Curr Opin Lipidol (2018)

Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation

por Mulvihill, Erin E., Huff, Murray W.
Publicado em 2012

Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors

por Mulvihill, Erin E., Drucker, Daniel J.
Publicado no Endocr Rev (2014)

Islet Health, Hormone Secretion, and Insulin Responsivity with Low-Carbohydrate Feeding in Diabetes

por Locatelli, Cassandra A. A., Mulvihill, Erin E.
Publicado no Metabolites (2020)

Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism

por Trzaskalski, Natasha A, Fadzeyeva, Evgenia, Mulvihill, Erin E
Publicado no Clin Med Insights Endocrinol Diabetes (2020)

Professional careers of 258 graduates of a 'fifth pathway' program.

por Pace, B. W., Rosner, F., Cohen, S., Mulvihill, J. E.
Publicado em 1991

Human subjects research : a handbook for institutional review boards /

por Greenwald, Robert A., Ryan, Mary Kay., Mulvihill, James E.
Publicado em 1982.

Chronic Brucella infection of the supra-patellar bursa with sinus formation.

por McDermott, M, O'Connell, B, Mulvihill, T E, Sweeney, E C
Publicado em 1994

Understanding Dietary Intervention-Mediated Epigenetic Modifications in Metabolic Diseases

por Asif, Shaza, Morrow, Nadya M., Mulvihill, Erin E., Kim, Kyoung-Han
Publicado no Front Genet (2020)

Plasma Myokine Concentrations After Acute Exercise in Non-obese and Obese Sedentary Women

por Garneau, Léa, Parsons, Stephanie A., Smith, Steven R., Mulvihill, Erin E., Sparks, Lauren M., Aguer, Céline
Publicado no Front Physiol (2020)

Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor

por Allister, Emma M., Mulvihill, Erin E., Barrett, P. Hugh R., Edwards, Jane Y., Carter, Lindsey P., Huff, Murray W.
Publicado em 2008

The gut hormone receptor GIPR links energy availability to the control of hematopoiesis

por Pujadas, Gemma, Varin, Elodie M., Baggio, Laurie L., Mulvihill, Erin E., Bang, K.W.Annie, Koehler, Jacqueline A., Matthews, Dianne, Drucker, Daniel J.
Publicado no Mol Metab (2020)

Hematopoietic cell– versus enterocyte-derived dipeptidyl peptidase-4 differentially regulates triglyceride excursion in mice

por Varin, Elodie M., Hanson, Antonio A., Beaudry, Jacqueline L., Nguyen, My-Anh, Cao, Xiemin, Baggio, Laurie L., Mulvihill, Erin E., Drucker, Daniel J.
Publicado no JCI Insight (2020)

GLP-1 Receptor Expression Within the Human Heart

por Baggio, Laurie L, Yusta, Bernardo, Mulvihill, Erin E, Cao, Xiemin, Streutker, Catherine J, Butany, Jagdish, Cappola, Thomas P, Margulies, Kenneth B, Drucker, Daniel J
Publicado no Endocrinology (2018)

Physiological roles of the GIP receptor in murine brown adipose tissue

por Beaudry, Jacqueline L., Kaur, Kiran D., Varin, Elodie M., Baggio, Laurie L., Cao, Xiemin, Mulvihill, Erin E., Bates, Holly E., Campbell, Jonathan E., Drucker, Daniel J.
Publicado no Mol Metab (2019)

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance

por Mulvihill, Erin E., Allister, Emma M., Sutherland, Brian G., Telford, Dawn E., Sawyez, Cynthia G., Edwards, Jane Y., Markle, Janet M., Hegele, Robert A., Huff, Murray W.
Publicado em 2009

Naringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr(−/−) mice

por Assini, Julia M., Mulvihill, Erin E., Sutherland, Brian G., Telford, Dawn E., Sawyez, Cynthia G., Felder, Sarah L., Chhoker, Sanjiv, Edwards, Jane Y., Gros, Robert, Huff, Murray W.
Publicado em 2013

The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice

por Beaudry, Jacqueline L., Kaur, Kiran Deep, Varin, Elodie M., Baggio, Laurie L., Cao, Xiemin, Mulvihill, Erin E., Stern, Jennifer H., Campbell, Jonathan E., Scherer, Phillip E., Drucker, Daniel J.
Publicado no Mol Metab (2019)

Inactivation of the cardiomyocyte glucagon-like peptide-1 receptor (GLP-1R) unmasks cardiomyocyte-independent GLP-1R-mediated cardioprotection()()

por Ussher, John R., Baggio, Laurie L., Campbell, Jonathan E., Mulvihill, Erin E., Kim, Minsuk, Kabir, M. Golam, Cao, Xiemin, Baranek, Benjamin M., Stoffers, Doris A., Seeley, Randy J., Drucker, Daniel J.
Publicado em 2014

Myeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice

por LeBlond, Nicholas D., Ghorbani, Peyman, O’Dwyer, Conor, Ambursley, Nia, Nunes, Julia R. C., Smith, Tyler K. T., Trzaskalski, Natasha A., Mulvihill, Erin E., Viollet, Benoit, Foretz, Marc, Fullerton, Morgan D.
Publicado no J Lipid Res (2020)